Germany’s PharmaSGP Predicts Market Turnaround Despite Difficult First Half

Germany's PharmaSGP blamed ongoing lockdowns for falling first-half sales, but said it could see light at the end of the tunnel, with the OTC market expected to recover in the second half of the year.

• Source: Shutterstock

Germany’s PharmaSGP GmbH posted turnover down by a fifth in the first half of 2021 as the effects of the COVID-19 pandemic continued to impact sales of its consumer health and cosmetics brands.

“Nationwide lockdowns hit our target markets hard, resulting in less footfall in pharmacies, among other effects,” commented CEO Natalie Weigand....

More from Earnings

More from Business